A.I Could Create New Drugs Faster Than Any Human Team
Atomwise, a San Francisco-based startup and Y Combinator alum, has built a system it calls AtomNet (pdf), which attempts to generate potential drugs for diseases like Ebola and multiple sclerosis.
Atomwise's system only generates potential drugs the compounds created by the neural network aren't guaranteed to be safe, and need to go through the same drug trials and safety checks as anything else on the market.
The company believes that the speed at which it can generate trial-ready drugs based on previous safe molecular interactions is what sets it apart.
"You can take an interaction between a drug and huge biological system and you can decompose that to smaller and smaller interactive groups.
To generate the drugs, the model starts with a 3D model of a molecule for example a protein that gives a cancer cell a growth advantage.
ENTERPRISE MANUFACTURING VISIBILITY
Real-time visibility of factory and machine performance from across your company delivered on an intelligent, secure, and scalable platform.
VIGILENT - DYNAMIC COOLING MANAGEMENT
Protecting uptime and tenant comfort while reducing energy costs.
Platform to help data scientists deploy models as web services in minutes, without IT.
HYPEREXTRACT FOR FORMS
Reduce manual sorting, data entry, and rekeying by 70-90% out of the box, with further reductions as the system learns from processing more documents.
Artificial Intelligence meets Business Intelligence